Small Molecules & Enzymology

Enzyme Inhibitors & Activators

Targeting metabolic pathways, allosteric regulation, and therapeutic mechanisms with high-potency small molecules.

Complete control over enzyme activity is crucial for dissecting biological pathways and validating therapeutic targets. To achieve this, researchers need molecular tools that can both decrease and increase enzymatic function with precision.

High-potency enzyme inhibitors and enzyme activators provide total command over experimental systems, enabling groundbreaking discoveries across oncology, cardiovascular research, metabolic disease, and neurology.

Precision Modulation

Whether suppressing hyperactive kinase signaling or boosting underperforming metabolic enzymes, selecting bioactive small molecules with validated IC₅₀/EC₅₀ values is fundamental to reproducible data.

1. The Two Sides of Enzyme Regulation

Whether you need to apply the brakes or step on the gas, choosing the right molecule is essential. Understanding the distinct mechanisms of inhibitors and activators allows for precise target modulation:

Enzyme Inhibitors

Enzyme inhibitors are small molecules or peptides that bind to enzymes and decrease their catalytic activity. They are foundational tools for dissecting metabolic and signaling pathways. Mechanisms include competitive inhibition (directly blocking the active site), non-competitive inhibition (binding an allosteric site to alter catalytic geometry), and uncompetitive or irreversible inhibition.

Enzyme Activators

Enzyme activators bind to an enzyme and increase its catalytic rate or substrate affinity. They are critical for studying allosteric regulation and evaluating therapeutic strategies aimed at restoring function in underperforming biological pathways. Activators frequently bind allosteric sites, inducing conformational changes that stabilize the active enzyme state.

2. Key Inhibitors & Activators

Explore frequently researched small molecules foundational to oncology, metabolic disease, and cardiovascular research:

Molecule Name	Type	Biological Target(s)	Primary Research Area
Imatinib	Inhibitor	BCR-Abl, c-Kit, PDGF-R	Oncology (Leukemia, GISTs)
Osimertinib	Inhibitor	EGFR Tyrosine Kinase	Oncology (Lung Cancer)
Atorvastatin	Inhibitor	HMG-CoA Reductase	Cardiovascular Disease
Olaparib	Inhibitor	PARP1 / PARP2	Oncology (Ovarian, Breast)
Ivacaftor	Activator	CFTR Protein	Pulmonary / Cystic Fibrosis
Metformin	Activator	AMPK Pathway	Metabolic Disease (Diabetes)
Resveratrol	Activator	Sirtuin 1 (SIRT1)	Anti-Aging, Metabolism
AICAR	Activator	AMPK Pathway	Metabolism, Exercise Physiology

Explore More Small Molecules

3. Why Reagent Quality is Crucial

In experimental bioassays, small molecule quality is non-negotiable. Off-target binding, impurities, or inconsistent potency can compromise weeks of work. Biorbyt enforces strict analytical quality control:

• Verified Chemical Purity: HPLC and NMR validation eliminate toxic impurities and confounding side-effects.
• Guaranteed Potency: Ensures reliable IC₅₀ or EC₅₀ performance across cellular and cell-free assays.
• Batch-to-Batch Consistency: Provides the reproducibility necessary for long-term longitudinal studies and screening panels.